Click for best price
Adalimumab Injection Market Size, Share 2024
| Market size in 2023 |
US$ 1872.7 million
|
Forecast Market size by 2030 |
US$ 2698.8 million
|
| Growth Rate |
CAGR of 5.4% |
Number of Pages |
115 Pages |
The global Adalimumab Injection market was valued at US$ 1872.7 million in 2023 and is projected to reach US$ 2698.8 million by 2030, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
40mg/0.8ml Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Adalimumab Injection include AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, Celltrion, Cadila Pharmaceuticals, Bio-Thera Solutions, Ltd. and Hisun Biopharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Adalimumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adalimumab Injection. This report contains market size and forecasts of Adalimumab Injection in global, including the following market information:
- Global Adalimumab Injection Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Adalimumab Injection Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Adalimumab Injection companies in 2023 (%)
We surveyed the Adalimumab Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adalimumab Injection Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adalimumab Injection Market Segment Percentages, by Type, 2023 (%)
Global Adalimumab Injection Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adalimumab Injection Market Segment Percentages, by Application, 2023 (%)
Global Adalimumab Injection Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adalimumab Injection Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Adalimumab Injection revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Adalimumab Injection revenues share in global market, 2023 (%)
- Key companies Adalimumab Injection sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Adalimumab Injection sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Amgen
- Sandoz
- Fresenius Kabi
- Biogen
- Celltrion
- Cadila Pharmaceuticals
- Bio-Thera Solutions, Ltd.
- Hisun Biopharmaceutical
- Innovent Biologics
- Mylan
- Zydus Group
- Boehringer Ingelheim
- Jiangsu Chia Tai-Tianqing Pharmaceutical
- Shanghai Henlius Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adalimumab Injection, market overview.
Chapter 2: Global Adalimumab Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Adalimumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adalimumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adalimumab Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Adalimumab Injection Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 1872.7 million
|
| Forecast Market size by 2030 |
US$ 2698.8 million
|
| Growth Rate |
CAGR of 5.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adalimumab Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adalimumab Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adalimumab Injection Overall Market Size
2.1 Global Adalimumab Injection Market Size: 2023 VS 2030
2.2 Global Adalimumab Injection Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Adalimumab Injection Sales: 2019-2030
3 Company Landscape
3.1 Top Adalimumab Injection Players in Global Market
3.2 Top Global Adalimumab Injection Companies Ranked by Revenue
3.3 Global Adalimumab Injection Revenue by Companies
3.4 Global Adalimumab Injection Sales by Companies
3.5 Global Adalimumab Injection Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Adalimumab Injection Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Adalimumab Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adalimumab Injection Players in Global Market
3.8.1 List of Global Tier 1 Adalimumab Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Adalimumab Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Adalimumab Injection Market Size Markets, 2023 & 2030
4.1.2 40mg/0.8ml
4.1.3 20mg/0.4ml
4.2 By Type - Global Adalimumab Injection Revenue & Forecasts
4.2.1 By Type - Global Adalimumab Injection Revenue, 2019-2024
4.2.2 By Type - Global Adalimumab Injection Revenue, 2025-2030
4.2.3 By Type - Global Adalimumab Injection Revenue Market Share, 2019-2030
4.3 By Type - Global Adalimumab Injection Sales & Forecasts
4.3.1 By Type - Global Adalimumab Injection Sales, 2019-2024
4.3.2 By Type - Global Adalimumab Injection Sales, 2025-2030
4.3.3 By Type - Global Adalimumab Injection Sales Market Share, 2019-2030
4.4 By Type - Global Adalimumab Injection Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adalimumab Injection Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Adalimumab Injection Revenue & Forecasts
5.2.1 By Application - Global Adalimumab Injection Revenue, 2019-2024
5.2.2 By Application - Global Adalimumab Injection Revenue, 2025-2030
5.2.3 By Application - Global Adalimumab Injection Revenue Market Share, 2019-2030
5.3 By Application - Global Adalimumab Injection Sales & Forecasts
5.3.1 By Application - Global Adalimumab Injection Sales, 2019-2024
5.3.2 By Application - Global Adalimumab Injection Sales, 2025-2030
5.3.3 By Application - Global Adalimumab Injection Sales Market Share, 2019-2030
5.4 By Application - Global Adalimumab Injection Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Adalimumab Injection Market Size, 2023 & 2030
6.2 By Region - Global Adalimumab Injection Revenue & Forecasts
6.2.1 By Region - Global Adalimumab Injection Revenue, 2019-2024
6.2.2 By Region - Global Adalimumab Injection Revenue, 2025-2030
6.2.3 By Region - Global Adalimumab Injection Revenue Market Share, 2019-2030
6.3 By Region - Global Adalimumab Injection Sales & Forecasts
6.3.1 By Region - Global Adalimumab Injection Sales, 2019-2024
6.3.2 By Region - Global Adalimumab Injection Sales, 2025-2030
6.3.3 By Region - Global Adalimumab Injection Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Adalimumab Injection Revenue, 2019-2030
6.4.2 By Country - North America Adalimumab Injection Sales, 2019-2030
6.4.3 US Adalimumab Injection Market Size, 2019-2030
6.4.4 Canada Adalimumab Injection Market Size, 2019-2030
6.4.5 Mexico Adalimumab Injection Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Adalimumab Injection Revenue, 2019-2030
6.5.2 By Country - Europe Adalimumab Injection Sales, 2019-2030
6.5.3 Germany Adalimumab Injection Market Size, 2019-2030
6.5.4 France Adalimumab Injection Market Size, 2019-2030
6.5.5 U.K. Adalimumab Injection Market Size, 2019-2030
6.5.6 Italy Adalimumab Injection Market Size, 2019-2030
6.5.7 Russia Adalimumab Injection Market Size, 2019-2030
6.5.8 Nordic Countries Adalimumab Injection Market Size, 2019-2030
6.5.9 Benelux Adalimumab Injection Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Adalimumab Injection Revenue, 2019-2030
6.6.2 By Region - Asia Adalimumab Injection Sales, 2019-2030
6.6.3 China Adalimumab Injection Market Size, 2019-2030
6.6.4 Japan Adalimumab Injection Market Size, 2019-2030
6.6.5 South Korea Adalimumab Injection Market Size, 2019-2030
6.6.6 Southeast Asia Adalimumab Injection Market Size, 2019-2030
6.6.7 India Adalimumab Injection Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Adalimumab Injection Revenue, 2019-2030
6.7.2 By Country - South America Adalimumab Injection Sales, 2019-2030
6.7.3 Brazil Adalimumab Injection Market Size, 2019-2030
6.7.4 Argentina Adalimumab Injection Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Adalimumab Injection Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Adalimumab Injection Sales, 2019-2030
6.8.3 Turkey Adalimumab Injection Market Size, 2019-2030
6.8.4 Israel Adalimumab Injection Market Size, 2019-2030
6.8.5 Saudi Arabia Adalimumab Injection Market Size, 2019-2030
6.8.6 UAE Adalimumab Injection Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Adalimumab Injection Major Product Offerings
7.1.4 AbbVie Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Adalimumab Injection Major Product Offerings
7.2.4 Amgen Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Adalimumab Injection Major Product Offerings
7.3.4 Sandoz Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.3.5 Sandoz Key News & Latest Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Company Summary
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Adalimumab Injection Major Product Offerings
7.4.4 Fresenius Kabi Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.4.5 Fresenius Kabi Key News & Latest Developments
7.5 Biogen
7.5.1 Biogen Company Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Adalimumab Injection Major Product Offerings
7.5.4 Biogen Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.5.5 Biogen Key News & Latest Developments
7.6 Celltrion
7.6.1 Celltrion Company Summary
7.6.2 Celltrion Business Overview
7.6.3 Celltrion Adalimumab Injection Major Product Offerings
7.6.4 Celltrion Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.6.5 Celltrion Key News & Latest Developments
7.7 Cadila Pharmaceuticals
7.7.1 Cadila Pharmaceuticals Company Summary
7.7.2 Cadila Pharmaceuticals Business Overview
7.7.3 Cadila Pharmaceuticals Adalimumab Injection Major Product Offerings
7.7.4 Cadila Pharmaceuticals Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.7.5 Cadila Pharmaceuticals Key News & Latest Developments
7.8 Bio-Thera Solutions, Ltd.
7.8.1 Bio-Thera Solutions, Ltd. Company Summary
7.8.2 Bio-Thera Solutions, Ltd. Business Overview
7.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Major Product Offerings
7.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.8.5 Bio-Thera Solutions, Ltd. Key News & Latest Developments
7.9 Hisun Biopharmaceutical
7.9.1 Hisun Biopharmaceutical Company Summary
7.9.2 Hisun Biopharmaceutical Business Overview
7.9.3 Hisun Biopharmaceutical Adalimumab Injection Major Product Offerings
7.9.4 Hisun Biopharmaceutical Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.9.5 Hisun Biopharmaceutical Key News & Latest Developments
7.10 Innovent Biologics
7.10.1 Innovent Biologics Company Summary
7.10.2 Innovent Biologics Business Overview
7.10.3 Innovent Biologics Adalimumab Injection Major Product Offerings
7.10.4 Innovent Biologics Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.10.5 Innovent Biologics Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Adalimumab Injection Business Overview
7.11.3 Mylan Adalimumab Injection Major Product Offerings
7.11.4 Mylan Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.11.5 Mylan Key News & Latest Developments
7.12 Zydus Group
7.12.1 Zydus Group Company Summary
7.12.2 Zydus Group Adalimumab Injection Business Overview
7.12.3 Zydus Group Adalimumab Injection Major Product Offerings
7.12.4 Zydus Group Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.12.5 Zydus Group Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Adalimumab Injection Business Overview
7.13.3 Boehringer Ingelheim Adalimumab Injection Major Product Offerings
7.13.4 Boehringer Ingelheim Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
7.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Summary
7.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
7.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Major Product Offerings
7.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Key News & Latest Developments
7.15 Shanghai Henlius Biotech
7.15.1 Shanghai Henlius Biotech Company Summary
7.15.2 Shanghai Henlius Biotech Business Overview
7.15.3 Shanghai Henlius Biotech Adalimumab Injection Major Product Offerings
7.15.4 Shanghai Henlius Biotech Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.15.5 Shanghai Henlius Biotech Key News & Latest Developments
8 Global Adalimumab Injection Production Capacity, Analysis
8.1 Global Adalimumab Injection Production Capacity, 2019-2030
8.2 Adalimumab Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Adalimumab Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adalimumab Injection Supply Chain Analysis
10.1 Adalimumab Injection Industry Value Chain
10.2 Adalimumab Injection Upstream Market
10.3 Adalimumab Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adalimumab Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Adalimumab Injection in Global Market
Table 2. Top Adalimumab Injection Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Adalimumab Injection Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Adalimumab Injection Revenue Share by Companies, 2019-2024
Table 5. Global Adalimumab Injection Sales by Companies, (K Units), 2019-2024
Table 6. Global Adalimumab Injection Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Adalimumab Injection Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Adalimumab Injection Product Type
Table 9. List of Global Tier 1 Adalimumab Injection Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adalimumab Injection Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Adalimumab Injection Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Adalimumab Injection Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Adalimumab Injection Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Adalimumab Injection Sales (K Units), 2019-2024
Table 15. By Type - Global Adalimumab Injection Sales (K Units), 2025-2030
Table 16. By Application ? Global Adalimumab Injection Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Adalimumab Injection Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Adalimumab Injection Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Adalimumab Injection Sales (K Units), 2019-2024
Table 20. By Application - Global Adalimumab Injection Sales (K Units), 2025-2030
Table 21. By Region ? Global Adalimumab Injection Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Adalimumab Injection Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Adalimumab Injection Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Adalimumab Injection Sales (K Units), 2019-2024
Table 25. By Region - Global Adalimumab Injection Sales (K Units), 2025-2030
Table 26. By Country - North America Adalimumab Injection Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Adalimumab Injection Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Adalimumab Injection Sales, (K Units), 2019-2024
Table 29. By Country - North America Adalimumab Injection Sales, (K Units), 2025-2030
Table 30. By Country - Europe Adalimumab Injection Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Adalimumab Injection Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Adalimumab Injection Sales, (K Units), 2019-2024
Table 33. By Country - Europe Adalimumab Injection Sales, (K Units), 2025-2030
Table 34. By Region - Asia Adalimumab Injection Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Adalimumab Injection Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Adalimumab Injection Sales, (K Units), 2019-2024
Table 37. By Region - Asia Adalimumab Injection Sales, (K Units), 2025-2030
Table 38. By Country - South America Adalimumab Injection Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Adalimumab Injection Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Adalimumab Injection Sales, (K Units), 2019-2024
Table 41. By Country - South America Adalimumab Injection Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Adalimumab Injection Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Adalimumab Injection Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Adalimumab Injection Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Adalimumab Injection Sales, (K Units), 2025-2030
Table 46. AbbVie Company Summary
Table 47. AbbVie Adalimumab Injection Product Offerings
Table 48. AbbVie Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. AbbVie Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Adalimumab Injection Product Offerings
Table 52. Amgen Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Amgen Key News & Latest Developments
Table 54. Sandoz Company Summary
Table 55. Sandoz Adalimumab Injection Product Offerings
Table 56. Sandoz Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Sandoz Key News & Latest Developments
Table 58. Fresenius Kabi Company Summary
Table 59. Fresenius Kabi Adalimumab Injection Product Offerings
Table 60. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Fresenius Kabi Key News & Latest Developments
Table 62. Biogen Company Summary
Table 63. Biogen Adalimumab Injection Product Offerings
Table 64. Biogen Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Biogen Key News & Latest Developments
Table 66. Celltrion Company Summary
Table 67. Celltrion Adalimumab Injection Product Offerings
Table 68. Celltrion Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Celltrion Key News & Latest Developments
Table 70. Cadila Pharmaceuticals Company Summary
Table 71. Cadila Pharmaceuticals Adalimumab Injection Product Offerings
Table 72. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Cadila Pharmaceuticals Key News & Latest Developments
Table 74. Bio-Thera Solutions, Ltd. Company Summary
Table 75. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Offerings
Table 76. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Bio-Thera Solutions, Ltd. Key News & Latest Developments
Table 78. Hisun Biopharmaceutical Company Summary
Table 79. Hisun Biopharmaceutical Adalimumab Injection Product Offerings
Table 80. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Hisun Biopharmaceutical Key News & Latest Developments
Table 82. Innovent Biologics Company Summary
Table 83. Innovent Biologics Adalimumab Injection Product Offerings
Table 84. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Innovent Biologics Key News & Latest Developments
Table 86. Mylan Company Summary
Table 87. Mylan Adalimumab Injection Product Offerings
Table 88. Mylan Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Mylan Key News & Latest Developments
Table 90. Zydus Group Company Summary
Table 91. Zydus Group Adalimumab Injection Product Offerings
Table 92. Zydus Group Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Zydus Group Key News & Latest Developments
Table 94. Boehringer Ingelheim Company Summary
Table 95. Boehringer Ingelheim Adalimumab Injection Product Offerings
Table 96. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Boehringer Ingelheim Key News & Latest Developments
Table 98. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Summary
Table 99. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Offerings
Table 100. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Jiangsu Chia Tai-Tianqing Pharmaceutical Key News & Latest Developments
Table 102. Shanghai Henlius Biotech Company Summary
Table 103. Shanghai Henlius Biotech Adalimumab Injection Product Offerings
Table 104. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Shanghai Henlius Biotech Key News & Latest Developments
Table 106. Adalimumab Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Adalimumab Injection Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Adalimumab Injection Production by Region, 2019-2024 (K Units)
Table 109. Global Adalimumab Injection Production by Region, 2025-2030 (K Units)
Table 110. Adalimumab Injection Market Opportunities & Trends in Global Market
Table 111. Adalimumab Injection Market Drivers in Global Market
Table 112. Adalimumab Injection Market Restraints in Global Market
Table 113. Adalimumab Injection Raw Materials
Table 114. Adalimumab Injection Raw Materials Suppliers in Global Market
Table 115. Typical Adalimumab Injection Downstream
Table 116. Adalimumab Injection Downstream Clients in Global Market
Table 117. Adalimumab Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Adalimumab Injection Segment by Type in 2023
Figure 2. Adalimumab Injection Segment by Application in 2023
Figure 3. Global Adalimumab Injection Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Adalimumab Injection Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Adalimumab Injection Revenue, 2019-2030 (US$, Mn)
Figure 7. Adalimumab Injection Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Adalimumab Injection Revenue in 2023
Figure 9. By Type - Global Adalimumab Injection Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Adalimumab Injection Revenue Market Share, 2019-2030
Figure 11. By Type - Global Adalimumab Injection Sales Market Share, 2019-2030
Figure 12. By Type - Global Adalimumab Injection Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Adalimumab Injection Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Adalimumab Injection Revenue Market Share, 2019-2030
Figure 15. By Application - Global Adalimumab Injection Sales Market Share, 2019-2030
Figure 16. By Application - Global Adalimumab Injection Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Adalimumab Injection Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Adalimumab Injection Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Adalimumab Injection Revenue Market Share, 2019-2030
Figure 20. By Region - Global Adalimumab Injection Sales Market Share, 2019-2030
Figure 21. By Country - North America Adalimumab Injection Revenue Market Share, 2019-2030
Figure 22. By Country - North America Adalimumab Injection Sales Market Share, 2019-2030
Figure 23. US Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Adalimumab Injection Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Adalimumab Injection Sales Market Share, 2019-2030
Figure 28. Germany Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 29. France Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Adalimumab Injection Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Adalimumab Injection Sales Market Share, 2019-2030
Figure 37. China Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 41. India Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Adalimumab Injection Revenue Market Share, 2019-2030
Figure 43. By Country - South America Adalimumab Injection Sales Market Share, 2019-2030
Figure 44. Brazil Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Adalimumab Injection Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Adalimumab Injection Sales Market Share, 2019-2030
Figure 48. Turkey Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Adalimumab Injection Revenue, (US$, Mn), 2019-2030
Figure 52. Global Adalimumab Injection Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Adalimumab Injection by Region, 2023 VS 2030
Figure 54. Adalimumab Injection Industry Value Chain
Figure 55. Marketing Channels
